Regenerative Therapies Market – By Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], By Applications (Wounds & Dermal, Musculoskeletal, Oncology) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Regenerative Therapies Market held USD 8.5 billion in 2020 and is to grow with a CAGR of 15.7% from 2020-2030. Regenerative medicine is medicine principle that focuses on the replacement of tissues, human cells and organs in order to restore normal functionality. Regenerative medicine aims to renew or replace cells in the damaged and unfitting tissue or organ of human beings. The body's own cells can be encouraged to cure, or a patient with laboratories-grown cells and tissues can be therapied. It can treat incurable chronic disorders and conditions such as Alzheimer's disease, Parkinson's disease, diabetes, cardiac illness, kidney failure, osteoporosis and injuries to the spinal cord, etc.

Market Dynamics and Factors:

The main drivers for regenerative therapies market growth are the increasing prevalence of regenerative therapies globally. In recent decades, the incidence and spread of inherited diseases such as cardiovascular disease, chronic diseases such as cancer and diabetes and cystic fibrosis have increased significantly around the world. Cardiovascular disease is currently the leading cause of death worldwide. According to the WHO, around 17.9 million people die each year from cardiovascular disease, accounting for nearly 31% of all deaths globally. An increase in sedentary lifestyles, a change in diet and the presence of many people with major risk factors for developing cardiovascular disease (such as high blood pressure and obesity) and the incidence of cardiovascular disease could increase considerably over the next few years. As a result, the frequency and prevalence of cancer and diabetes worldwide has increased significantly in recent decades, and this trend is expected to continue in the coming years. According to the International Diabetes Federation (IDF), in 2015, approximately 415 million people worldwide had diabetes, and that number is expected to reach 642 million by 2040. In 2018, cancer is the second leading cause of death in the world and about 9.6 million deaths.

Market Segmentation:

Based on the type, the regenerative therapies market size is segmented into cell therapy, cell-based immunotherapy, tissue engineering, gene therapy. Cell Based Immunotherapy and cell therapy includes allogeneic & autologous products. On the basis of application, the regenerative therapies market trends segmentation includes wounds & dermal, musculoskeletal, oncology. Geographical breakdown and analysis of each of the aforementioned segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographic Analysis:

North America is the potential market in the regenerative therapies demand due to rising demand for these therapies in this region. Surging research activities in the field of regenerative medicine, introduction of CAR-T cell therapies as well as rising awareness of personalized medicine has led to establishment of stem cell banking and tissue engineering. Rising incidence of orthopedic diseases with increasing count of geriatric population is anticipated to drive the growth of regenerative therapies market.

Competitive Scenario:

Global regenerative therapies market, players capture majority of the market positioning. Key players enhancing the global regenerative therapies market size include Stryker Corporation, Medtronic Plc., Athersys, Inc., U.S. Stem Cell, Zimmer Biomet Holdings, Inc., Inc. (Bioheart, Inc.), Organogenesis, Inc., Integra Lifesciences, Acelity Holdings, Inc., Isto Biologics, and CryoLife, Inc.

Regenerative Therapies Market Report Scope